Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis

Nivolumab-Induced Myocarditis Concomitant with Myasthenia Gravis

We report a 69-year-old female patient with advanced lung cancer who developed myocarditis concomitant with myasthenia gravis (MG), also known as “Herzmyasthenie,” after 3 cycles of nivolumab administration. Her initial symptoms were general malaise and double vision. However, her myocarditis deteri...

Full description

Bibliographic Details
Main Authors: Yoko Fukasawa, Kazuya Sasaki, Maika Natsume, Makoto Nakashima, Shuji Ota, Kiyotaka Watanabe, Yoshihisa Takahashi, Fukuo Kondo, Ken Kozuma, Nobuhiko Seki
Format: Article
Language:English
Published: Karger Publishers 2017-09-01
Series:Case Reports in Oncology
Subjects:
Adenocarcinoma
Immunotherapy
Lung cancer
Nivolumab
Myocarditis
Myasthenia gravis
Herzmyasthenie
Anti-programmed cell death-1 monoclonal antibodies
Online Access:http://www.karger.com/Article/FullText/479958

Internet

http://www.karger.com/Article/FullText/479958

Similar Items